Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSK/NCPA medication therapy management pilot

Executive Summary

GlaxoSmithKline has partnered with the National Community Pharmacists Association on a pilot program examining how medication therapy management can help patients with uncontrolled asthma. The pilot, which launched March 15, has already enrolled nearly 240 of its target of 500 pharmacies, as of March 24. Patient interventions and communications with physicians will be conducted over a six-month period and will examine pharmacists' impact on delivering care services and improving health outcomes. NCPA has been looking to expand the use of medication therapy management programs (1"The Pink Sheet" Oct. 24, 2005, p. 13)...

You may also be interested in...



Pharmacists Aim To Expand Medication Therapy Management Past Medicare

The National Community Pharmacists Association is looking to use its Medicare Part D plan as a springboard to introduce remunerative medication therapy management into Medicaid and commercial plans starting in 2006

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047013

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel